Kazuhiro Nakato

A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease

Katsuya Harada, Kazuhiro Nakato, Junko Yarimizu et al. · European Journal of Pharmacology · 2012 · 60 citations

Alzheimer's Disease, Medicine, Cognitive Dysfunction +12

Pharmacological studies on YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT2A receptor antagonistic activity

Hiromi Takeuchi, Shin‐ichi Yatsugi, Kenichi Hatanaka et al. · European Journal of Pharmacology · 1997 · 40 citations

Molecular Pharmacology, Novel Antidepressant, Psychoactive Drug +7

Cytosolic and intranuclear calcium signals in rat basophilic leukemia cells as revealed by a confocal fluorescence Microscope

Kazuhiro Nakato, Tadahide Furuno, Kenji Inagaki et al. · European Journal of Biochemistry · 1992 · 33 citations

Engineering, Blood Cell, Cellular Physiology +17

Dopamine D₃ and D₄ Receptor Antagonists:  Synthesis and Structure−Activity Relationships of (<i>S</i>)-(+)-<i>N</i>-(1-Benzyl-3-pyrrolidinyl)-5-chloro-4- [(cyclopropylcarbonyl)amino]-2-methoxybenzamide (YM-43611) and Related Compounds

Junya Ohmori, Kyoichi Maeno, Kazuyuki Hidaka et al. · Journal of Medicinal Chemistry · 1996 · 28 citations · Full text

Phencyclidine-induced abnormal behaviors in rats as measured by the hole board apparatus

T. Morita, Rie Sonoda, Kazuhiro Nakato et al. · Psychopharmacology · 2000 · 22 citations

Psychoactive Drug, Behavioral Neuroscience, Phencyclidine-induced Abnormal Behaviors +13